MTMatthew K. Tobin

Matthew K. Tobin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Matthew K. Tobin has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Christian T. Sidebottom

    Department of Neurology, Semmes Murphey Clinic, University of Tennessee Health Sciences Center, Memphis (N.G., C.T.S.).

    3 shared publications
  • David Joseph Altschul

    Department of Neurological Surgery and Montefiore-Einstein Cerebrovascular Research Lab, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

    3 shared publications
  • Gary Defilipp

    Charlotte Radiology, Advocate Health, NC (G.D.).

    3 shared publications
  • Je Yeong Sone

    Department of Neurosurgery, Northshore University HealthSystem, Evanston, IL (W.J.A., J.Y.S.).

    3 shared publications
  • Justin Mascitelli

    Department of Neurosurgery, University of Texas Health Science Center at San Antonio (J.M., M.R.W.).

    3 shared publications
  • Krisztina Moldovan

    Department of Neurosurgery (R.T., K.M.), Warren Alpert School of Medicine at Brown University, Rhode Island Hospital, Providence

    3 shared publications

Latest Publications

  • Open Access

    Early Reperfusion in Basilar Artery Occlusion Stroke Managed With Tenecteplase Versus Alteplase Before Endovascular Treatment

    by Dylan N. Wolman, Rahul R. Karamchandani, Kwadwo Darko, Tyler M. Bielinski, Nitin Goyal, Jeremy B. Rhoten, Mahesh V. Jayaraman, Christian T. Sidebottom, Bradley A. Gross, Alhamza R. Al-Bayati, et al.

    BACKGROUND: Timely reperfusion is a critical determinant of favorable outcomes in basilar artery occlusion (BAO) stroke. We aimed to examine whether the choice of thrombolytic agent predicts early reperfusion (ER) in BAO stroke managed with tenecteplase versus alteplase before endovascular treatment. METHODS: This was a retrospective, multicenter US cohort of consecutive patients with BAO from 14 stroke centers treated with tenecteplase or alteplase within 4.5 hours of last known well before endovascular treatment. The primary end point was ER, defined as angiographic ER (expanded Thrombolysis in Cerebral Infarction grade 2b to 3 on the first diagnostic angiogram), or clinical ER, defined as substantial neurological improvement precluding endovascular treatment and a good functional outcome (modified Rankin Scale score 0–3). RESULTS: Among 163 patients with BAO and a median last known well-to-needle time of 135 minutes (interquartile range, 100–193) and last known well-to-puncture time of 228 minutes (interquartile range, 166–307), ER was observed in 27 (16.6%) patients. Rates of ER were comparable between tenecteplase (14/75, 18.7%) and alteplase (13/88, 14.8%; adjusted odds ratio, 1.082 [95% CI, 0.444–2.631]; P =0.862). In addition, rates of angiographic ER and clinical ER subgroups did not differ between thrombolytic agents. Higher Basilar Artery on Computed Tomography Angiography scores and a nonatherothrombotic cause independently predicted ER. In multivariable analysis, a good functional outcome was associated with younger age, lower stroke burden, and shorter last known well-to-puncture time. CONCLUSIONS: In BAO treated within 4.5 hours of last known well, tenecteplase and alteplase produced comparable early reperfusion rates. Achieving ER did not modify the association between thrombolytic agent and good functional outcome, consistent with rapid thrombectomy in patients with no ER.

  • Open Access

    Tenecteplase Versus Alteplase for First‐Pass Reperfusion in Basilar Artery Occlusion Stroke Thrombectomy

    by Dylan N. Wolman, Rahul R. Karamchandani, Sina Hemmer, Tyler M. Bielinski, Nitin Goyal, Jeremy B. Rhoten, Mahesh V. Jayaraman, Christian T. Sidebottom, Bradley A. Gross, Alhamza R. Al‐Bayati, et al.

    Objective: The first‐pass effect (FPE), defined as excellent reperfusion after a single attempt, is associated with improved outcomes in large vessel occlusion stroke. We evaluated whether intravenous tenecteplase (TNK) compared with alteplase (TPA) increases the likelihood of FPE in basilar artery occlusion (BAO). Methods: We analyzed 163 consecutive BAO patients treated with intravenous TNK or TPA within 4.5 h of last known well across 14 U.S. stroke systems (January 2020–August 2024). Patients with early reperfusion ( n = 27) or aborted procedures ( n = 3) were excluded. Multivariable ordinal and logistic regression identified predictors of FPE (expanded Thrombolysis in Cerebral Infarction [eTICI] 2c–3) and modified FPE (mFPE, eTICI 2b–3), and FPE/mFPE association with 90‐day outcomes (modified Rankin Scale [mRS] 0–3). Results: FPE occurred in 55 of 133 patients (41.4%) and was more frequent with TNK than TPA (51.7% vs 32.9%, p = 0.029). TNK was independently associated with higher odds of FPE (adjusted odds ratio [aOR] 2.37, 95% confidence interval [CI] 1.13–4.98, p = 0.023) and mFPE (aOR 2.74, 95% CI 1.20–6.25, p = 0.017). Both FPE and mFPE were independently associated with ambulatory outcomes at 90‐days (FPE: aOR 2.94, 95% CI 1.18–7.33, p = 0.021; mFPE: aOR 5.11, 95% CI 1.81–14.43, p = 0.002). TNK compared with TPA did not show an independent association with functional outcome. Interpretation: In this multicenter BAO cohort, TNK increased the odds of achieving FPE compared with TPA. As FPE strongly predicted functional recovery, these findings suggest TNK may confer a reperfusion advantage with potential clinical benefit, although a direct outcome effect was not demonstrated. ANN NEUROL 2026;99:692–704


  • Open Access

    Basilar Artery Occlusion Stroke Managed With Tenecteplase Versus Alteplase Before Endovascular Treatment (BAO‐TNK)

    by Rahul R. Karamchandani, Dylan N. Wolman, Tyler M. Bielinski, Nitin Goyal, Jeremy B. Rhoten, Mahesh V. Jayaraman, Christian T. Sidebottom, Bradley A. Gross, Alhamza R. Al‐Bayati, Mohamed F. Doheim, et al.

    Objective: To compare the effectiveness and safety of tenecteplase (TNK) versus alteplase (TPA) in patients with basilar artery occlusion prior to endovascular treatment (EVT). Methods: In this retrospective multicenter study (BAO‐TNK), we analyzed consecutive BAO patients from 14 U.S. stroke systems who received TNK or TPA within 4.5 h of last known well and were referred for EVT (01/2020‐08/2024). Multivariable logistic regression models were adjusted for age, sex, NIH Stroke Scale (NIHSS), posterior circulation Alberta Stroke Program Early CT Score (pc‐ASPECTS), last‐known‐well‐to‐door time, and stroke etiology. Outcomes included 90‐day modified Rankin Scale (mRS), reperfusion rates, and intracranial hemorrhage (ICH) per Heidelberg classification. Results: Of 163 BAO patients, 75 (46.0%) received TNK and 88 (54.0%) received TPA. Rates of 90‐day good functional outcome (mRS 0–3) were comparable between groups (TNK: 61.8% vs. TPA: 48.8%, adjusted odds ratio [aOR] 1.372, 95% CI 0.616–3.054, p = 0.439). No significant differences were observed in rates of pre‐thrombectomy early reperfusion (18.7% vs. 14.8%, aOR 0.933, 95% CI 0.369–2.359, p = 0.884), post‐thrombectomy final reperfusion (97.3% vs. 92.0%, aOR 2.133, 95% CI 0.376–12.116, p = 0.393), 90‐day mortality (32.4% vs. 39.5%, aOR 0.989, 95% CI 0.436–2.244, p = 0.979), or symptomatic ICH (4.0% vs. 4.5%, aOR 1.319, 95% CI 0.245–7.114, p = 0.747). Predictors of favorable outcome included younger age, lower NIHSS, higher pc‐ASPECTS, shorter LKW‐to‐puncture time, and non‐atherothrombotic stroke etiology. Interpretation: In BAO stroke, TNK and TPA administered within 4.5 h pre‐EVT were associated with similar functional outcomes, reperfusion success and hemorrhage rates.


  • Open Access

    Kyphoplasty as a Treatment Option for Traumatic Burst Fractures: A Case Series Evaluating Patient Outcomes and Functional Benefits

    by Anoop S. Chinthala, Barnabas Obeng-Gyasi, Trenton A. Line, Matthew K. Tobin, Gordon Mao, Bradley N. Bohnstedt

    Background/Objectives: Kyphoplasty and vertebroplasty are minimally invasive approaches for spinal fractures aiming to reduce pain, increase mobilization, and prevent further vertebral height loss. Their efficacy in treating burst fractures has been questioned due to fragment mobility and concerns for cement leakage. We aim to report outcomes in patients who underwent kyphoplasty for spinal burst fractures. Methods: We conducted a retrospective review of patients with burst fractures treated from 2018 to 2023. Those who underwent kyphoplasty or vertebroplasty and had follow-up imaging were included. Clinical characteristics and follow-up outcomes were obtained through chart review. The primary outcome was the need for surgical intervention after kyphoplasty. Results: We identified ten patients (mean age 67.9 years, range 36–93 years) with burst fractures who underwent kyphoplasty/vertebroplasty. Six received kyphoplasty/vertebroplasty within 1 week of injury and four between 1 and 4 months post-injury. Nine patients had a TLICS score of 2, and one had a TLICS score of 5. Kyphoplasty/vertebroplasty was performed for pain management in seven patients and significant/worsening vertebral height loss in three patients. At follow-up, 70% of patients reported an improvement in pain and 75% of patients reported improved mobility. One patient experienced progression of an L2 burst fracture but improved with conservative management. No patient required additional surgical fixation. Conclusions: In this series of ten patients with spinal burst fractures, standalone kyphoplasty was a safe and effective treatment. Our findings suggest kyphoplasty may be a viable treatment option for select spinal traumatic burst fractures, offering potential pain relief and mobility improvement in the short term.

  • Generational Changes in Lumbar Spinal Canal Dimensions: Findings from a Sample U.S. Population

    by Matthew K. Tobin, Cristian Gragnaniello, Jack Horwitz, Felicia W. Sun, Constantin Schizas, Sergey Neckrysh


  • Open Access

    Activated Mesenchymal Stem Cells Induce Recovery Following Stroke Via Regulation of Inflammation and Oligodendrogenesis

    by Matthew K. Tobin, Terilyn K. L. Stephen, Kyra L. Lopez, Melissa R. Pergande, Amelia M. Bartholomew, Stephanie M. Cologna, Orly Lazarov

    Background: Brain repair mechanisms fail to promote recovery after stroke, and approaches to induce brain regeneration are scarce. Mesenchymal stem cells ( MSC ) are thought to be a promising therapeutic option. However, their efficacy is not fully elucidated, and the mechanism underlying their effect is not known. Methods and Results: The middle cerebral artery occlusion model was utilized to determine the efficacy of interferon‐γ–activated mesenchymal stem cells ( aMSC γ) as an acute therapy for stroke. Here we show that treatment with aMSC γ is a more potent therapy for stroke than naive MSC . aMSC γ treatment results in significant functional recovery assessed by the modified neurological severity score and open‐field analysis compared with vehicle‐treated animals. aMSC γ‐treated animals showed significant reductions in infarct size and inhibition of microglial activation. The aMSC γ treatment suppressed the hypoxia‐induced microglial proinflammatory phenotype more effectively than treatment with naive MSC . Importantly, treatment with aMSC γ induced recruitment and differentiation of oligodendrocyte progenitor cells to myelin‐producing oligodendrocytes in vivo. To elucidate the mechanism underlying high efficacy of aMSC γ therapy, we examined the secretome of aMSC γ and compared it to that of naive MSC . Intriguingly, we found that aMSC γ but not nMSC upregulated neuron‐glia antigen 2, an important extracellular signal and a hallmark protein of oligodendrocyte progenitor cells. Conclusions: These results suggest that activation of MSC with interferon‐γ induces a potent proregenerative, promyelinating, and anti‐inflammatory phenotype of these cells, which increases the potency of aMSC γ as an effective therapy for ischemic stroke.


  • Pica in a Child with Anterior Cingulate Gyrus Oligodendroglioma: Case Report

    by Shivani D. Rangwala, Matthew K. Tobin, Daniel M. Birk, Jonathan T. Butts, Dimitrios C. Nikas, Yoon S. Hahn

    The anterior cingulate gyrus (ACG) is a continued focus of research as its exact role in brain function and vast connections with other anatomical locations is not fully understood. A review of the literature illustrates the role the ACG likely plays in cognitive and emotional processing, as well as a modulating role in motor function and goal-oriented behaviors. While lesions of the cingulate gyrus are rare, each new case broadens our understanding of its role in cognitive neuroscience and higher order processing. The authors present the case of an 8-year-old boy with a 1-month history of staring spells, agitated personality, and hyperphagia notable for the consumption of paper, who was found to have a 3-cm tumor in the left ACG. Following surgical resection of the tumor, his aggressive behavior and pica were ameliorated and the patient made an uneventful recovery, with no evidence of recurrence over the last 6 years since surgical resection. Here we discuss a unique behavioral presentation of pica, along with a review of the current literature, to illustrate functions of the ACG relevant to the location of the lesion.


  • Rare Genetic Causes of Stroke

    by M.K. Tobin, F.D. Testai

  • Spontaneous Resolution of Spinal Epidural Hematoma Resulting from Domestic Child Abuse: Case Report

    by Shivani D. Rangwala, Daniel M. Birk, Matthew K. Tobin, Yoon S. Hahn, Demetrios C. Nikas

    Nonaccidental head injury, as seen in domestic child abuse cases, is often associated with spinal injury, and spinal subdural hematoma is the most frequent diagnosis. While spinal epidural hematomas are a rare occurrence, the incidence of spontaneous epidural hematomas occurring in nonaccidental head injury patients is even lower. Epidural hematomas often result in acute focal neurological deficits necessitating emergent neurosurgical intervention. In patients without focal neurological deficits, conservative management may allow for spontaneous resolution of the epidural hematoma. The authors present the case of a 2-year-old boy with a large spinal epidural hematoma resulting after an event of nonaccidental injury, specifically, domestic child abuse. This patient exhibited no focal neurological deficits and was managed conservatively without surgical clot evacuation. On a follow-up visit, repeat imaging studies demonstrated a stable resolution of spinal epidural hematoma, providing further support for the safety of conservative management in these patients.